DOWNREGULATION OF ORGANIC CATION TRANSPORTERS OCT1 (SLC22A1) AND OCT3 (SLC22A3) IN HUMAN HEPATOCELLULAR CARCINOMA AND THEIR PROGNOSTIC SIGNIFICANCE

被引：0
|
作者：
Knapstein, J. [1 ]
Heise, M.
Lautem, A.
Schattenberg, J. [1 ]
Galle, P. R. [1 ]
Otto, G.
Schuchmann, M. [1 ]
Zimmermann, T. [1 ]
机构：
[1] Univ Med Mainz, Med Klin, Mainz, Germany
来源：
JOURNAL OF HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
10.1016/S0168-8278(12)60298-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
285
引用
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [31] Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3)
    Bourdet, DL
    Pritchard, JB
    Thakker, DR
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (03): : 1288 - 1297
  • [32] Transcriptional regulation of murine Slc22a1 (Oct1) by peroxisome proliferator agonist receptor-α and -γ
    Nie, WX
    Sweetser, S
    Rinella, M
    Green, RM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2005, 288 (02): : G207 - G212
  • [33] SLC22A1/OCT1 Genotype Affects O-desmethyltramadol Exposure in Newborn Infants
    Matic, Maja
    de Wildt, Saskia N.
    Elens, Laure
    de Hoon, Jan N.
    Annaert, Pieter
    Tibboel, Dick
    van Schaik, Ron H. N.
    Allegaert, Karel
    [J]. THERAPEUTIC DRUG MONITORING, 2016, 38 (04) : 487 - 492
  • [34] ASSOCIATION OF VARIANTS OF SLC22A1 (OCT1) WITH THE RESPONSE TO IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
    Manuel, Perez-Encinas
    Angueira Francisco, Barros
    Jose, Rabunal Martinez M.
    Redondo Carlos, Ulibarrena
    Varela Nicolas, Diaz
    Garcia Celsa, Quinteiro
    Martinez Teresa, Gonzalez
    Perez Sonia, Gonzalez
    Vence Natalia, Alonso
    Lopez Angeles, Bendana
    Arias Jose, Diaz
    Mendez Isabel, Abuin
    Blanco Aitor, Abuin
    Perez Laura, Bao
    Orgeira Adrian, Mosquera
    Jose Luis, Bello Lopez
    [J]. HAEMATOLOGICA, 2016, 101 : 178 - 178
  • [35] Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 (Oct1 [Slc22a1]) gene
    Jonker, JW
    Wagenaar, E
    Mol, CAAM
    Buitelaar, M
    Koepsell, H
    Smit, JW
    Schinkel, AH
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (16) : 5471 - 5477
  • [36] The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin
    Tzvetkov, M. V.
    Vormfelde, S. V.
    Balen, D.
    Meineke, I.
    Schmidt, T.
    Sehrt, D.
    Sabolic, I.
    Koepsell, H.
    Brockmoeller, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (03) : 299 - 306
  • [37] Glucocorticoid receptor regulates organic cation transporter 1 (OCT1, SLC22A1) expression via HNF4α upregulation in primary human hepatocytes
    Alice Rulcova
    Lucie Krausova
    Tomas Smutny
    Radim Vrzal
    Zdenek Dvorak
    Ramiro Jover
    Petr Pavek
    [J]. Pharmacological Reports, 2013, 65 : 1322 - 1335
  • [38] Glucocorticoid receptor regulates organic cation transporter 1 (OCT1, SLC22A1) expression via HNF4α, upregulation in primary human hepatocytes
    Rulcova, Alice
    Krausova, Lucie
    Smutny, Tomas
    Vrzal, Radim
    Dvorak, Zdenek
    Jover, Ramiro
    Pavek, Petr
    [J]. PHARMACOLOGICAL REPORTS, 2013, 65 (05) : 1322 - 1335
  • [39] Metformin Pharmacogenetics: Effects of SLC22A1, SLC22A2, and SLC22A3 Polymorphisms on Glycemic Control and HbA1c Levels
    Al-Eitan, Laith N.
    Almomani, Basima A.
    Nassar, Ahmad M.
    Elsaqa, Barakat Z.
    Saadeh, Nesreen A.
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2019, 9 (01):
  • [40] Interaction of organic cation transporter 3 (SLC22A3) and amphetamine
    Zhu, Hao-Jie
    Appel, David I.
    Gruendemann, Dirk
    Markowitz, John S.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2010, 114 (01) : 142 - 149
12345